Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Kim Sarah EEVP, CLO & Corporate Secretary | Tax withholding | F | $73.6 23 sh | Sep 28, 2026 |
| 9 | Stillwell Mary-LeeSVP and Controller | Grant or award | A | $585 43 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 9 | Sanderson Katherine ElizabethSee Remarks | Tax withholding | F | $36K 232 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 8 | Sousa Mauad BrunoDirector | Derivative conversion | C | $665K 8,000 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 8 | Rubin KevinChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $1,797 9 sh | Sep 28, 2026 traded Sep 25, 2026 |
| 8 | Rubin KevinChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $4,107 20 sh | Sep 28, 2026 traded Sep 25, 2026 |
| 8 | Rubin KevinChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $623 3 sh | Sep 28, 2026 traded Sep 25, 2026 |
| 8 | Rubin KevinChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $7,313 36 sh | Sep 28, 2026 traded Sep 25, 2026 |
| 8 | Rubin KevinChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $824 4 sh | Sep 28, 2026 traded Sep 25, 2026 |
| 8 | Rubin KevinChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $37K 189 sh | Sep 28, 2026 traded Sep 25, 2026 |
| 8 | Rubin KevinChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $19K 100 sh | Sep 28, 2026 traded Sep 25, 2026 |
| 8 | Rubin KevinChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $592 3 sh | Sep 28, 2026 traded Sep 25, 2026 |
| 8 | Rubin KevinChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $1,010 5 sh | Sep 28, 2026 traded Sep 25, 2026 |
| 8 | Wells Preston WendellVP, Chief Financial Officer | Other acquisition or disposition | J | — 109 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 8 | Sousa Mauad BrunoDirector | Derivative conversion | C | $666K 24.0K sh | Sep 28, 2026 traded Sep 24, 2026 |
| 8 | Rubin KevinChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $4,022 20 sh | Sep 28, 2026 traded Sep 25, 2026 |
| 8 | Rubin KevinChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $23K 118 sh | Sep 28, 2026 traded Sep 25, 2026 |
| 8 | Rubin KevinChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $2,453 12 sh | Sep 28, 2026 traded Sep 25, 2026 |
| 8 | Tejada JenniferDirector, Executive Chair | Open-market sale · 10b5-1 plan | SELL | $120K 8,000 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 7 | Lie SeanChief Technology Officer | Derivative conversion · 10b5-1 plan | C | — 120.0K sh | Sep 28, 2026 traded Sep 25, 2026 |
| 7 | Golechha DipakEVP, Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $2.08M 5,301 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 6 | Lie SeanChief Technology Officer | Gift · 10b5-1 plan | G | — 36.0K sh | Sep 28, 2026 traded Sep 25, 2026 |
| 5 | Raub ChristopherEVP JFI; CEO PPM America | Grant or award | A | — 2 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Duffey Gregory ADirector | Grant or award | A | $3,195 51 sh | Sep 28, 2026 traded Sep 28, 2026 |
| 5 | Radakovich Lynn VojvodichDirector | Grant or award | A | — 419 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Bhalla Narinder PalChief Medical Officer | Grant or award | A | — 54.8K sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Hutman Hannah W.Director | Grant or award | A | $6,180 153 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Wray Peter HDirector | Grant or award | A | $6,180 153 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Raub ChristopherEVP JFI; CEO PPM America | Grant or award | A | — 18 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Dorrance Bennett JRDirector | Grant or award | A | — 2,204 sh | Sep 28, 2026 traded Sep 25, 2026 |
| 5 | Snook Gregory IDirector | Grant or award | A | $6,453 103 sh | Sep 28, 2026 traded Sep 28, 2026 |
| 5 | Malady KyleEVP and Group CEO-VZ Business | Grant or award | A | $1,739 129 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Raub ChristopherEVP JFI; CEO PPM America | Grant or award | A | — 53 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Otero Jose ManuelChief Operating Officer | Grant or award | A | — 54.8K sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Tamayo Louis EdwardChief Financial Officer | Grant or award | A | — 54.8K sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Raub ChristopherEVP JFI; CEO PPM America | Grant or award | A | — 25 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Raub ChristopherEVP JFI; CEO PPM America | Grant or award | A | — 19 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Keeler Anne BDirector | Grant or award | A | $6,180 153 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 4 | Golechha DipakEVP, Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $866K 2,200 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 4 | Tsao DavidDirector, Chief Technology Officer | Option exercise · 10b5-1 plan | M | $9,332 3,333 sh | Sep 28, 2026 traded Sep 24, 2026 |